share_log

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burnett Patrick

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burnett Patrick

Arcutis Biotherapeutics | 4:持股變動聲明-高管 Burnett Patrick
美股SEC公告 ·  2024/11/19 00:10

牛牛AI助理已提取核心訊息

Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a series of stock transactions between November 14, 2024, and November 15, 2024. Burnett engaged in both the acquisition and disposal of common stock shares. On November 14, Burnett acquired 18,377 shares at no cost, an action described as the exercise or conversion of derivative security. On the same day, Burnett sold 50,749 shares at a price of $10.2945 per share, followed by the sale of 18,377 shares at the same price, both transactions classified as open market or private sales. The following day, Burnett acquired 100 shares, again at no cost, and sold the same number of shares at $10.03 each. After these transactions, Burnett held a total of 128,669 shares of Arcutis Biotherapeutics. The total value of the disposed shares amounted to approximately $712,620.61.
Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a series of stock transactions between November 14, 2024, and November 15, 2024. Burnett engaged in both the acquisition and disposal of common stock shares. On November 14, Burnett acquired 18,377 shares at no cost, an action described as the exercise or conversion of derivative security. On the same day, Burnett sold 50,749 shares at a price of $10.2945 per share, followed by the sale of 18,377 shares at the same price, both transactions classified as open market or private sales. The following day, Burnett acquired 100 shares, again at no cost, and sold the same number of shares at $10.03 each. After these transactions, Burnett held a total of 128,669 shares of Arcutis Biotherapeutics. The total value of the disposed shares amounted to approximately $712,620.61.
與arcutis biotherapeutics, inc. [ARQT]相關的帕特里克·伯內特在2024年11月14日至2024年11月15日之間完成了一系列股票交易。伯內特進行了普通股的收購和處置。11月14日,伯內特以零成本收購了18,377股,這一行爲被描述爲衍生證券的行使或轉換。同一天,伯內特以每股10.2945美元的價格出售了50,749股,隨後以同樣的價格出售了18,377股,這兩筆交易被歸類爲公開市場或私人銷售。第二天,伯內特以零成本再次收購了100股,並以每股10.03美元的價格出售相同數量的股票。在這些交易後,伯內特持有共計128,669股arcutis biotherapeutics。處置股票的總價值約爲712,620.61美元。
與arcutis biotherapeutics, inc. [ARQT]相關的帕特里克·伯內特在2024年11月14日至2024年11月15日之間完成了一系列股票交易。伯內特進行了普通股的收購和處置。11月14日,伯內特以零成本收購了18,377股,這一行爲被描述爲衍生證券的行使或轉換。同一天,伯內特以每股10.2945美元的價格出售了50,749股,隨後以同樣的價格出售了18,377股,這兩筆交易被歸類爲公開市場或私人銷售。第二天,伯內特以零成本再次收購了100股,並以每股10.03美元的價格出售相同數量的股票。在這些交易後,伯內特持有共計128,669股arcutis biotherapeutics。處置股票的總價值約爲712,620.61美元。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。

    聲明

    本頁的譯文內容由軟件翻譯。富途將竭力但卻不能保證翻譯內容之準確和可靠,亦不會承擔因任何不準確或遺漏而引起的任何損失或損害。